Procter & Gamble CO

The Procter & Gamble Company announced the closing of a $352.2 million public offering of Floating Rate Notes due 2076.

The Procter & Gamble Company has successfully closed a substantial public offering of notes across multiple maturities, bolstering its capital structure.

The Procter & Gamble Company announced first quarter fiscal year 2027 results, showcasing a 4.0% organic sales growth driven by volume and mix, while maintaining full-year guidance despite anticipated cost headwinds.

The Procter & Gamble Company announced first quarter fiscal year 2027 results, with net sales increasing 4.0% to $23.3 billion and organic sales also rising 4.0%, while diluted EPS grew 1% to $1.97.

The Procter & Gamble Company's 8-K filing details the outcomes of its 2026 Annual Meeting of Shareholders, showing overwhelming support for director elections and the ratification of its independent auditor.

The Procter & Gamble Company announced a quarterly dividend of $1.0885 per share and confirmed the election of all 12 director nominees at its Annual Meeting of Shareholders.

The Procter & Gamble Company reported a 4.0% increase in net sales for the first quarter of fiscal year 2027, reaching $23.3 billion, driven by volume and pricing, while navigating higher commodity costs.

Procter & Gamble reports a 7% increase in quarterly net sales to $21.2 billion, driven by volume growth and pricing, despite ongoing restructuring costs.

Procter & Gamble reports a 1% net sales increase to $22.2 billion for Q2 FY26, with diluted EPS down 5% due to significant restructuring charges.

Procter & Gamble reported a 20% increase in net earnings to $4.8 billion for the first quarter, alongside a new $1.5-$2.0 billion restructuring plan and a $5 billion share repurchase program.

Procter & Gamble's Q3 2025 results reveal a slight dip in net sales offset by earnings growth driven by prior-year impairment charges, while the company navigates currency fluctuations and restructuring efforts.

Procter & Gamble's second quarter results show a mix of growth and challenges, with a 2% increase in net sales but a significant impact from restructuring and currency fluctuations.

The Procter & Gamble Company announced its fiscal year 2026 results, showcasing a 3% increase in net sales to $87.0 billion and a 2% rise in diluted EPS to $6.62.

Procter & Gamble reported increased net earnings and diluted EPS for fiscal year 2025, driven by reduced selling, general, and administrative costs and the absence of a prior-year impairment charge, despite ongoing restructuring efforts.

Procter & Gamble's 2024 annual report highlights a 2% increase in net sales, driven by pricing and organic growth, alongside a 12% increase in core earnings per share, while also addressing macroeconomic headwinds and strategic restructuring.

Paul Gama, CEO- Health Care of PROCTER & GAMBLE Co, sold 2,894 shares of common stock on October 30, 2026 for $165.00 per share.

Moses Victor Javier Aguilar, Chf Rsch, Dev & Innov Officer of PROCTER & GAMBLE Co, sold 18,812 shares of common stock on October 30, 2026 for $164.43 per share.

Sundar G. Raman, CEO-Fabric Home & Habitat Care of PROCTER & GAMBLE Co, sold 38,253 shares of common stock on October 30, 2026 for $165.00 per share.

Shailesh Jejurikar, Chairman, President and CEO and a Director of PROCTER & GAMBLE Co, sold 35,000 shares of common stock on October 23, 2026 for $163.09 per share.

Balaji Purushothaman, Chief Human Resources Officer of PROCTER & GAMBLE Co, sold 4,181 shares of common stock on October 23, 2026 for $160.71 per share.

Paul Gama, CEO- Health Care of PROCTER & GAMBLE Co, sold 4,331 shares of common stock on October 23, 2026 for $161.27 per share.

Procter & Gamble announces its 2026 Annual Meeting of Shareholders, detailing director nominees, executive compensation, and shareholder proposals.

Procter & Gamble announces its 2025 Annual Meeting of Shareholders, detailing proposals including director elections, executive compensation, and a new stock plan.

Procter & Gamble details leadership changes, including a new CEO, proposes a new stock and incentive plan, and outlines shareholder voting matters for its upcoming annual meeting.

Procter & Gamble's annual shareholder meeting will be held virtually on October 8, 2024, with proposals including the election of directors, ratification of the accounting firm, executive compensation, and a shareholder proposal on pay gap reporting.

Procter & Gamble's proxy statement details the election of directors, executive compensation, and shareholder proposals for the upcoming annual meeting.

Vanguard Capital Management disclosed a beneficial ownership of 7.52% of Procter & Gamble's common stock as of March 31, 2026.

The Vanguard Group, Inc. filed an amended Schedule 13G, reporting 0% beneficial ownership of Procter & Gamble Co/The common stock following an internal realignment.

The Vanguard Group reported an increased beneficial ownership of 10.04% in Procter & Gamble Co/The common stock as of August 29, 2025.